Aktien Sensor

Fujitsu Ltd. has strengthened its position in the artificial intelligence (AI) market through a strategic collaboration with NVIDIA, aiming to deliver a full-stack AI infrastructure that accelerates AI adoption across various industries while preser…

DraftKings Inc. is navigating a shifting landscape of prediction markets and consumer behavior, with opportunities for growth through diversification, data analytics, and cross-generational appeal, but also facing risks such as regulatory backlash, …

eBay’s share price has shown a modest upward trend, driven by the company’s robust fundamentals and strategic focus on supporting small businesses, amidst a mixed performance in the broader Nasdaq-100 index.

Telenor ASA, a leading international telecommunications group, has partnered with Infosys to implement Oracle Cloud Human Capital Management, aiming to standardize HR processes, enhance employee productivity, and improve workforce experience.

SMC Corp, a Japanese industrial specialist, has received a ‘High-Conviction Outperform’ rating from CLSA, but a closer look at its business fundamentals, regulatory landscape, and competitive dynamics reveals nuanced drivers and potential blind spot…

Union Pacific Corporation has achieved a milestone in labor negotiations with the ratification of a new five-year contract with locomotive engineers, which is expected to have a positive impact on the company’s operational efficiency, regulatory com…

Flutter Entertainment PLC’s share price has declined due to concerns over its new Kalshi product, but analysts remain bullish on the company’s long-term prospects and dominant position in the mobile and online gambling market.

Prudential Financial Inc. is poised to report stable third-quarter 2025 earnings, driven by premium growth, improving claims experience, and investment income, amidst a bullish market sentiment fueled by artificial intelligence innovations.

Roche Holding AG has achieved significant market access and development milestones, including regulatory approvals for several new cancer treatments, a proposed reduction in value-added tax in Germany, and a robust pipeline of combination therapies,…

Incyte Corporation’s share price has surged due to its strategic focus on proprietary small-molecule therapeutics, particularly the CALR antibody program, which has positioned the company as a top performer in the S&P 500 healthcare sector.